Ohio State University Comprehensive Cancer Center
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
- Website
- http://www.cancer.osu.edu
Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors
Not Applicable
Completed
- Conditions
- Prognostic Stage IB Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IIB Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8
- First Posted Date
- 2023-01-06
- Last Posted Date
- 2025-03-25
- Target Recruit Count
- 21
- Registration Number
- NCT05674578
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery
Completed
- Conditions
- Breast Carcinoma
- First Posted Date
- 2022-10-18
- Last Posted Date
- 2023-03-02
- Target Recruit Count
- 31
- Registration Number
- NCT05583981
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Neuropsychological Care for Maintaining Quality of Life After Radiation Therapy in Patients with Brain Metastases
Not Applicable
Active, not recruiting
- Conditions
- Metastatic Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the Brain
- First Posted Date
- 2022-08-16
- Last Posted Date
- 2025-02-10
- Target Recruit Count
- 110
- Registration Number
- NCT05503251
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Evaluating E-Cigarette Nicotine Form, Concentration, and Flavors Among Youth
Not Applicable
Completed
- Conditions
- E-cigarette Use
- First Posted Date
- 2022-07-14
- Last Posted Date
- 2024-11-22
- Target Recruit Count
- 88
- Registration Number
- NCT05458895
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Free-Base Nicotine or Nicotine Salt e-Liquids in Current E-Cigarette Smokers, PeloPET Study
Not Applicable
Completed
- Conditions
- Cigarette Smoking-Related Carcinoma
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2025-03-24
- Target Recruit Count
- 21
- Registration Number
- NCT05455086
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Hookah Additive Research to Inform Product Standards
Not Applicable
Completed
- Conditions
- Tobacco-Related Carcinoma
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2024-12-31
- Target Recruit Count
- 54
- Registration Number
- NCT05453773
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Keto-Brain:Investigating the Use of Ketogenic Diets in Brain Metastases
Not Applicable
Recruiting
- Conditions
- Brain Metastases, Adult
- First Posted Date
- 2022-06-23
- Last Posted Date
- 2025-01-31
- Target Recruit Count
- 24
- Registration Number
- NCT05428852
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Early Phase 1
Recruiting
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Endocrine Therapy-Induced AlopeciaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage I Breast Cancer AJCC v8Prognostic Stage IA Breast Cancer AJCC v8
- Interventions
- First Posted Date
- 2022-06-14
- Last Posted Date
- 2025-04-04
- Target Recruit Count
- 50
- Registration Number
- NCT05417308
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Hyperthermic Intraperitoneal Chemotherapy with Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of Stage III or IV Ovarian, Fallopian Tube or Peritoneal Cancer
Early Phase 1
Recruiting
- Conditions
- Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Serous AdenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous AdenocarcinomaOvarian Serous AdenocarcinomaPrimary Peritoneal Endometrioid AdenocarcinomaPrimary Peritoneal Serous AdenocarcinomaStage III Fallopian Tube Cancer AJCC V8Stage III Ovarian Cancer AJCC V8
- Interventions
- Procedure: Cytoreductive SurgeryDrug: Hyperthermic Intraperitoneal ChemotherapyOther: Quality-of-Life AssessmentOther: Questionnaire AdministrationProcedure: Biospecimen CollectionProcedure: Diagnostic Imaging
- First Posted Date
- 2022-06-13
- Last Posted Date
- 2025-02-14
- Target Recruit Count
- 45
- Registration Number
- NCT05415709
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung
Not Applicable
Withdrawn
- Conditions
- Lung Non-Small Cell CarcinomaStage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IA1 Lung Cancer AJCC v8Head and Neck Squamous Cell CarcinomaStage IB Lung Cancer AJCC v8Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8
- Interventions
- Other: Best PracticeOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- Locations
- πΊπΈ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States